Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/1745-8315.12072 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
STAR LIGHT Study: XBB.1.5 COVID-19 mRNA Vaccines Boost Systemic but Not Mucosal Immunity Against the SARS-CoV-2 JN.1 Variant in Patients with Chronic Liver Disease.
Vaccines (Basel)
October 2024
Department of Gastroenterology and Hepatology, Cantonal Hospital St. Gallen, 9007 St. Gallen, Switzerland.
Background: Patients with chronic liver disease (CLD) have impaired vaccine immunogenicity and an excess risk of severe COVID-19. While variant-adapted COVID-19 mRNA vaccines are recommended for vulnerable individuals, their efficacy in patients with CLD has not been studied.
Methods: We present the first evaluation of XBB.
The Legacy of Hermann Rorschach and His Inkblots: Portrait of a Man or Mental Disease?
Cureus
August 2024
Internal Medicine, Baylor Scott & White Medical Center - Temple, Temple, USA.
Article Synopsis
- Hermann Rorschach was a Swiss psychiatrist known for creating inkblots to assess mental health and personality types, with his foundational ideas stemming from a 1911 dissertation on reflex hallucinations.
- After Rorschach's death in 1922, his work was popularized in the U.S. by Samuel Beck and Bruno Klopfer, who later adapted the inkblots for intelligence and personality testing.
- The application of Rorschach's method to analyze the "Nazi personality" at the Nuremberg Trials was controversial due to interpreter bias, while modern critiques question the validity and relevance of the Rorschach tests in clinical settings.
Systemic and Mucosal Immunogenicity of Monovalent XBB.1.5-Adapted COVID-19 mRNA Vaccines in Patients with Inflammatory Bowel Disease.
Vaccines (Basel)
July 2024
Department of Gastroenterology and Hepatology, Cantonal Hospital St. Gallen, 9007 St. Gallen, Switzerland.
Recently updated COVID-19 mRNA vaccines encode the spike protein of the omicron subvariant XBB.1.5 and are recommended for patients with inflammatory bowel disease (IBD) on immunosuppressive treatment.
View Article and Find Full Text PDFRevisiting Rorschach test and Minnesota Multiphasic Personality Inventory-II patterns in Kraepelinian vs. DSM-wise Schizophrenia: How They Differ and What It Means for Diagnosis.
Sci Prog
July 2024
Department of Psychiatry, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Objective: This retrospective chart review study aimed to investigate the differences in the Rorschach test and Minnesota Multiphasic Personality Inventory (MMPI)-II profiles among patients with Kraepelinian schizophrenia, those with DSM-wise schizophrenia, and controls. Kraepelinian schizophrenia is characterised by a chronic, deteriorative disease course and a predominance of negative symptoms.
Methods: Patients with Kraepelinian schizophrenia were selected based on medical record reviews.
The present study was undertaken to determine if the findings of Ales et al. (2020) could be replicated and extended, especially in light of the replication crisis in psychology and the social sciences. Ales et al.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!